Clinical trials
Phase 2 Stomach Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 6 |
| Terminated | 6 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federation Francophone de Cancerologie Digestive | 3 |
| GERCOR - Multidisciplinary Oncology Cooperative Group | 3 |
| AstraZeneca | 2 |
| Hoffmann-La Roche | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Sanofi | 2 |
| Amgen | 1 |
| Apollomics Inc. | 1 |
| Arcus Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 39 |
| Ovarian Neoplasms | 6 |
| Colorectal Neoplasms | 4 |
| Endometrial Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
| Breast Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.